Trials / Completed
CompletedNCT01439308
Intranasal SB-705498 in Non-allergic Rhinitis Patients
A Randomized, Double Blind, Placebo Controlled Study to Assessthe Effect of Intranasal Single Dose SB-705498 on the Response Tointranasal Capsaicin Challenge in Non-allergic Rhinitis Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to look at the affect of SB-705498 on rhinitis symptoms, as induced by capsaicin challenge
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | SB-705498 placebo |
| DRUG | SB-705498 | 12mg intranasal SB-705498 |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-04-01
- Completion
- 2010-05-01
- First posted
- 2011-09-23
- Last updated
- 2016-12-01
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01439308. Inclusion in this directory is not an endorsement.